Viewing Study NCT03059251


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-01-01 @ 8:33 PM
Study NCT ID: NCT03059251
Status: COMPLETED
Last Update Posted: 2020-04-17
First Post: 2017-02-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module